Plaintiffs' Request To Reinstate 13 Risperdal Cases
Plaintiffs' Request To Reinstate 13 Risperdal Cases
Introduction
Plaintiffs' request to reinstate 13 Risperdal gynecomastia cases was denied by a Pennsylvania state appeals panel agreeing with the trial judge that the claims were preempted by Michigan's drug shield law and that the plaintiffs could not prove that the fraud exception applied to their claims. Janssen Pharmaceuticals Inc. is the defendant named in this litigation.
Comments
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
Categories: Roundup
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Categories: Zimmer Hip/Knee Replacement
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
Categories: Hernia Mesh
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…